Mass General Brigham study highlights the efficacy of proton therapy in reducing toxicity while enhancing outcomes for ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Long-term use of proton pump inhibitors (PPIs) did not appear to be associated with an increased risk of gastric cancer, according to a population-based case-control study in five Nordic countries.

The long-term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Mass General Brigham study highlights the efficacy of proton therapy in reducing toxicity while enhancing outcomes for patients with lower grade gliomas compared to traditional radiotherapy ...

The potential link between use of proton pump inhibitors and gastric cancer has been an ongoing controversial subject since the drugs entered the market in the late 1980s. Long-term use of proton pump ...

Sources of error that may lead to false association include PPI use shortly before diagnosis, short-term PPI use.

"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...